Pro Medicus (ASX:PME) reported Thursday that its earnings per diluted share in the fiscal first half rose to AU$0.4944 from AU$0.3461 per diluted share a year earlier.
Analysts polled by Visible Alpha were expecting EPS of AU$0.4957.
Revenue from contracts with customers for the six months to Dec. 31, 2024, was AU$97.2 million, up from AU$74.1 million in the same period a year earlier. Total revenue rose to AU$100.8 million from AU$76.3 million. Analysts surveyed by Visible Alpha expected total revenue of AU$99.7 million.
The board declared an interim dividend of AU$0.25 per share, up from the AU$0.18 per share in the previous reported period, payable on March 21 to shareholders on record as of Feb. 28.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.